As founding Director of the Center for Regenerative Medicine at Scripps Research Institute in La Jolla, Calif., Dr. Loring focuses on supporting collaboration and strategic partnerships in human stem cell research, as well as training the next generation of stem cell scientists. She also currently serves as Professor of Developmental Neurobiology with the Institute.
“Dr. Loring’s knowledge and background in the growing field of stem cell research will be an invaluable addition to Histogen’s Scientific Advisory Board,” said Dr. Robert Kellar, Vice President of Research & Development for Histogen. “We are excited to utilize her expertise as we move forward with research, and prepare to launch our first product, a research kit for stem cell growth.”
Dr. Loring’s extensive experience in the field includes research and management positions at biotechnology companies such as Hana Biologics, GenPharm International, Molecular Dynamics, and Incyte Genomics, as well as founding and serving as chief scientific officer of Arcos BioScience (now part of Novocell). Most recently, Dr. Loring acted as Co-director of the Stem Cell Center at Burnham Institute for Medical Research.
“Histogen’s unique technology shows significant promise for the fields of regenerative medicine and stem cell research,” said Dr. Loring. “I look forward to contributing to the Company’s research initiatives and product development.”
Histogen’s proprietary bioreactor technology enables the Company to simulate the embryonic environment, creating products that are embryonic-like in nature with a variety of product applications from research kits to hair growth.
About Histogen Histogen, launched in 2007, seeks to redefine regenerative medicine by developing a series of high value products without the use of embryonic stem cells or animal products. Through Histogen's proprietary bioreactors that mimic the embryonic environment, newborn fibroblasts are encouraged to naturally produce the vital proteins and growth factors from which the company has developed its rich product portfolio. Histogen has two product families - ExceltrixTM, Histogen's human Extracellular Matrix (ECM) and HGEN-001, Histogen's proprietary liquid formula. For more information, please visit http://www.histogeninc.com.